Harmony Biosciences (HRMY) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 14, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by May 13, 2026.

Voting matters and shareholder proposals

• Election of four Class III directors to serve until the 2029 annual meeting, with nominees Geno J. Germano, Troy Ignelzi, Ron Philip, and Andreas Wicki, Ph.D.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation in accordance with SEC disclosure rules.

• Provision for other business to be transacted as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.